- Home
- MVST vs KURA Comparison
MVST vs KURA Comparison
Compare MVST & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$2.87
HOLD
Current Price
$8.47
Company Overview
Basic Information| Metric | MVST | KURA |
|---|---|---|
| Founded | 2006 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 987.8M | 830.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MVST | KURA |
|---|---|---|
| Price | $2.87 | $8.47 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 10 |
| Target Price | $6.00 | ★ $26.88 |
| AVG Volume (30 Days) | ★ 4.5M | 1.4M |
| Earning Date | 11-10-2025 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $444,504,000.00 | $104,029,000.00 |
| Revenue This Year | $24.19 | $88.72 |
| Revenue Next Year | $17.70 | $76.50 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 19.82 | N/A |
| 52 Week Low | $1.09 | $5.41 |
| 52 Week High | $7.12 | $12.49 |
Technical Indicators
Market Signals| Indicator | MVST | KURA |
|---|---|---|
| Relative Strength Index (RSI) | 40.65 | 35.97 |
| Support Level | $2.78 | $8.13 |
| Resistance Level | $3.16 | $9.18 |
| Average True Range (ATR) | 0.22 | 0.45 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 11.62 | 14.98 |
Price Performance
Historical Comparison MVST
KURA
About MVST Microvast Holdings Inc.
Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extends from core battery chemistry to battery packs.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.